Value Creation Plans

Turn an investment thesis into a value creation plan with sized levers, named owners, milestones and leading indicators, then track it monthly and report slips honestly.

Free · Mac (Apple silicon) and Windows · v1.0.5 · Other platforms

Then open the Marketplace in the app, search for Value Creation Plans, and click Install. It goes into your own files, and works offline from then on.

Before you start: this plan is general information to help your team organise its work. It is not financial, investment, tax, accounting or legal advice, and it does not recommend any product, investment or deal. Rules differ between countries, so check decisions that matter with qualified, licensed advisers in the countries concerned. Investing can lose money, and raising or managing other people's money is regulated in most countries.

What it installs.

1

Pillar

1

Area

50

Projects

200

Starter tasks

💹 Private Equity & Venture Capital

Value Creation Plans

Turning the investment thesis into a value creation plan: revenue, margin and cash levers, owners and milestones, board tracking and honest updates when it slips.

  1. Value creation hypotheses drawn from the IC memo
  2. Entry baseline for EBITDA, cash and operating KPIs
  3. EBITDA bridge from entry to the exit case
  4. Lever inventory across revenue, margin and cash
  5. Initiative charter for each chosen lever
  6. Named owners and decision rights for the plan
  7. Milestones and leading indicators per initiative
  8. Management alignment workshop on the plan
  9. Costs to achieve and resourcing budget
  10. Monthly value creation tracker review
  11. Value creation section of the board pack
  12. Benefits realisation log reconciled to the accounts
  13. Quarterly reprioritisation of initiatives
  14. Weekly initiative owner stand-up
  15. Plan risk and dependency register
  16. Slip escalation and honest recovery note
  17. Annual plan reset alongside the budget
  18. Leading indicator scorecard for initiatives
  19. Price waterfall and discount leakage analysis
  20. Procurement and cost of goods lever basics
  21. Sales force effectiveness diagnostic
  22. Working capital lever on receivables, stock and payables
  23. Lean operations basics for site improvements
  24. Digital and automation initiatives sized in EBITDA terms
  25. Returns attribution across growth, margin, multiple and debt paydown
  26. Case studies of plans that worked and plans that failed
  27. Prioritisation matrix for value, effort and timing
  28. Build, buy or partner decision for a missing capability
  29. Deciding where consultants are worth the fee
  30. Kill or continue review for a stalled initiative
  31. SKU and customer rationalisation decision
  32. Site footprint consolidation decision
  33. Growth capex allocation across initiatives
  34. Organisation changes needed to deliver the plan
  35. Value creation plan approval at the board
  36. Year-one value creation results review
  37. Mid-hold value creation reassessment
  38. Plan progress update for lenders
  39. Annual value creation offsite with management
  40. Owning the plan as portfolio company CEO
  41. CFO's role in quantifying and evidencing the plan
  42. Delivering one initiative as a functional leader
  43. Building the value creation model as a deal associate
  44. Value creation plan for a minority investment
  45. Recovery plan when the business misses the base case
  46. Standalone and stranded cost plan for a carve-out
  47. Commercial excellence pilot with test and control groups
  48. Sustainability levers sized in value terms
  49. Plan stress test against downside lever outcomes
  50. Look-back on past plans versus delivered value

Where it starts.

Each project arrives with its purpose, milestones and first tasks written out. Here is how the first three read.

Value creation hypotheses drawn from the IC memo

An approved IC memo usually promises four to eight sources of value, scattered across the thesis, the model and the diligence findings. Pulling each one out as a testable hypothesis with its assumed EBITDA or cash effect gives the plan a starting list that the committee has already signed up to, rather than a fresh wish list written after closing.

First tasks

  • Open the final IC memo and highlight every sentence that claims future value
  • Match each claim to the line in the base case model that carries it
  • Ask the agent to draft a hypothesis table from the highlighted memo extracts
  • Review the table with the deal lead and strike anything diligence disproved

Entry baseline for EBITDA, cash and operating KPIs

Without a frozen baseline, every later improvement can be argued away as seasonality, a one-off or a restated number. Locking the closing EBITDA, normalised for the quality of earnings adjustments, plus net working capital and ten or so operating KPIs, gives every initiative a fixed point to be measured against.

First tasks

  • Request the final QoE report and closing balance sheet from the deal folder
  • List each normalisation adjustment and the amount behind it
  • Agree the definition of each operating KPI with the CFO
  • Save the signed baseline as a read-only version with today's date

EBITDA bridge from entry to the exit case

Boards and lenders understand a plan fastest as a bridge: entry EBITDA on the left, exit case EBITDA on the right, and one bar for each lever in between. Building it forces the team to show how much of the exit case depends on market growth, how much on management action, and how much is still unexplained.

First tasks

  • Pull entry and exit year EBITDA from the base case model
  • Assign each hypothesis to one bar of the bridge
  • Separate market growth using the volume assumptions in the model
  • Reconcile the bridge total to the model and note any gap

Make it yours.

Install Value Creation Plans, then tell Aurum the date you're aiming for. It checks whether the plan fits the weeks you actually have.

Free · Mac (Apple silicon) and Windows · v1.0.5 · Other platforms

Blueprints are general information to help you organise your own work. They are not medical, financial, legal or other professional advice. See the Terms.